Trapp T, Holsboer F
Max-Planck-Institute of Psychiatry, Department of Neuroendocrinology, Munich, Germany.
Biochem Biophys Res Commun. 1995 Oct 4;215(1):286-91. doi: 10.1006/bbrc.1995.2464.
The human mineralocorticoid receptor (MR) binds the agonists aldosterone and cortisol and the antagonist progesterone with a comparably high affinity. We used limited proteolysis of human MR synthesized by in vitro translation to detect structural alterations induced by these different endogenous ligands. Steroid binding induces a conformational change within the receptor protein. This structural alteration renders a fragment of MR resistant to proteolysis. Agonists and antagonist vary in how well they protect the MR fragment against proteolysis. But the two agonists also differ in their ability to protect, indicating that agonists and antagonists, but also different agonists, may induce distinct conformational changes. Ligand-independent removal of MR-associated heat-shock proteins induces no detectable structural change but completely prevents ligand binding of MR.
人盐皮质激素受体(MR)以相对较高的亲和力结合激动剂醛固酮和皮质醇以及拮抗剂孕酮。我们利用体外翻译合成的人MR进行有限蛋白酶解,以检测这些不同内源性配体诱导的结构改变。类固醇结合会在受体蛋白内诱导构象变化。这种结构改变使MR的一个片段对蛋白酶解具有抗性。激动剂和拮抗剂在保护MR片段免受蛋白酶解方面的效果有所不同。但这两种激动剂在保护能力上也存在差异,表明激动剂和拮抗剂,以及不同的激动剂,可能会诱导不同的构象变化。与MR相关的热休克蛋白的非配体依赖性去除不会诱导可检测到的结构变化,但会完全阻止MR与配体的结合。